Literature DB >> 25119036

Required enhancer-matrin-3 network interactions for a homeodomain transcription program.

Dorota Skowronska-Krawczyk1, Qi Ma1, Michal Schwartz2, Kathleen Scully1, Wenbo Li1, Zhijie Liu1, Havilah Taylor1, Jessica Tollkuhn1, Kenneth A Ohgi1, Dimple Notani1, Yoshinori Kohwi3, Terumi Kohwi-Shigematsu3, Michael G Rosenfeld1.   

Abstract

Homeodomain proteins, described 30 years ago, exert essential roles in development as regulators of target gene expression; however, the molecular mechanisms underlying transcriptional activity of homeodomain factors remain poorly understood. Here investigation of a developmentally required POU-homeodomain transcription factor, Pit1 (also known as Pou1f1), has revealed that, unexpectedly, binding of Pit1-occupied enhancers to a nuclear matrin-3-rich network/architecture is a key event in effective activation of the Pit1-regulated enhancer/coding gene transcriptional program. Pit1 association with Satb1 (ref. 8) and β-catenin is required for this tethering event. A naturally occurring, dominant negative, point mutation in human PIT1(R271W), causing combined pituitary hormone deficiency, results in loss of Pit1 association with β-catenin and Satb1 and therefore the matrin-3-rich network, blocking Pit1-dependent enhancer/coding target gene activation. This defective activation can be rescued by artificial tethering of the mutant R271W Pit1 protein to the matrin-3 network, bypassing the pre-requisite association with β-catenin and Satb1 otherwise required. The matrin-3 network-tethered R271W Pit1 mutant, but not the untethered protein, restores Pit1-dependent activation of the enhancers and recruitment of co-activators, exemplified by p300, causing both enhancer RNA transcription and target gene activation. These studies have thus revealed an unanticipated homeodomain factor/β-catenin/Satb1-dependent localization of target gene regulatory enhancer regions to a subnuclear architectural structure that serves as an underlying mechanism by which an enhancer-bound homeodomain factor effectively activates developmental gene transcriptional programs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119036      PMCID: PMC4358797          DOI: 10.1038/nature13573

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

Review 1.  [Transcription factors and the nuclear matrix].

Authors:  N I S'iakste; T G S'iakste
Journal:  Mol Biol (Mosk)       Date:  2001 Sep-Oct

2.  Nuclear matrins: identification of the major nuclear matrix proteins.

Authors:  H Nakayasu; R Berezney
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

3.  Matrin 3: chromosomal distribution and protein interactions.

Authors:  Michael J Zeitz; Kishore S Malyavantham; Brandon Seifert; Ronald Berezney
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

4.  Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold.

Authors:  J Mirkovitch; M E Mirault; U K Laemmli
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

Review 5.  Molecular biology of HMGA proteins: hubs of nuclear function.

Authors:  R Reeves
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

6.  A conserved DNA sequence in homoeotic genes of the Drosophila Antennapedia and bithorax complexes.

Authors:  W McGinnis; M S Levine; E Hafen; A Kuroiwa; W J Gehring
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

Review 7.  Finding distal regulatory elements in the human genome.

Authors:  Nathaniel D Heintzman; Bing Ren
Journal:  Curr Opin Genet Dev       Date:  2009-10-23       Impact factor: 5.578

8.  A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency.

Authors:  S Radovick; M Nations; Y Du; L A Berg; B D Weintraub; F E Wondisford
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

9.  Signal-specific co-activator domain requirements for Pit-1 activation.

Authors:  L Xu; R M Lavinsky; J S Dasen; S E Flynn; E M McInerney; T M Mullen; T Heinzel; D Szeto; E Korzus; R Kurokawa; A K Aggarwal; D W Rose; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  Characterization of SAF-A, a novel nuclear DNA binding protein from HeLa cells with high affinity for nuclear matrix/scaffold attachment DNA elements.

Authors:  H Romig; F O Fackelmayer; A Renz; U Ramsperger; A Richter
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

View more
  27 in total

1.  Nuclear matrix revisited?

Authors:  Dorota Skowronska-Krawczyk; Michael G Rosenfeld
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.

Authors:  Ritu Chaudhary; Berkley Gryder; Wendy S Woods; Murugan Subramanian; Matthew F Jones; Xiao Ling Li; Lisa M Jenkins; Svetlana A Shabalina; Min Mo; Mary Dasso; Yuan Yang; Lalage M Wakefield; Yuelin Zhu; Susan M Frier; Branden S Moriarity; Kannanganattu V Prasanth; Pablo Perez-Pinera; Ashish Lal
Journal:  Elife       Date:  2017-06-05       Impact factor: 8.140

3.  Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly.

Authors:  Sreejith J Nair; Lu Yang; Dario Meluzzi; Soohwan Oh; Feng Yang; Meyer J Friedman; Susan Wang; Tom Suter; Ibraheem Alshareedah; Amir Gamliel; Qi Ma; Jie Zhang; Yiren Hu; Yuliang Tan; Kenneth A Ohgi; Ranveer Singh Jayani; Priya R Banerjee; Aneel K Aggarwal; Michael G Rosenfeld
Journal:  Nat Struct Mol Biol       Date:  2019-03-04       Impact factor: 15.369

Review 4.  Enhancers as non-coding RNA transcription units: recent insights and future perspectives.

Authors:  Wenbo Li; Dimple Notani; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2016-03-07       Impact factor: 53.242

Review 5.  Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.

Authors:  Vikas Malik; Dennis Zimmer; Ralf Jauch
Journal:  Cell Mol Life Sci       Date:  2018-01-15       Impact factor: 9.261

6.  Enhancer-bound LDB1 regulates a corticotrope promoter-pausing repression program.

Authors:  Feng Zhang; Bogdan Tanasa; Daria Merkurjev; Chijen Lin; Xiaoyuan Song; Wenbo Li; Yuliang Tan; Zhijie Liu; Jie Zhang; Kenneth A Ohgi; Anna Krones; Dorota Skowronska-Krawczyk; Michael G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 7.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

8.  All Hormone-Producing Cell Types of the Pituitary Intermediate and Anterior Lobes Derive From Prop1-Expressing Progenitors.

Authors:  Shannon W Davis; Jessica L Keisler; María I Pérez-Millán; Vanessa Schade; Sally A Camper
Journal:  Endocrinology       Date:  2016-01-26       Impact factor: 4.736

9.  Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.

Authors:  Feng Yang; Qi Ma; Zhijie Liu; Wenbo Li; Yuliang Tan; Chunyu Jin; Wubin Ma; Yiren Hu; Jia Shen; Kenneth A Ohgi; Francesca Telese; Wen Liu; Michael G Rosenfeld
Journal:  Mol Cell       Date:  2017-05-04       Impact factor: 17.970

10.  High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency.

Authors:  Peter Gergics; Cathy Smith; Hironori Bando; Alexander A L Jorge; Denise Rockstroh-Lippold; Sebastian A Vishnopolska; Frederic Castinetti; Mariam Maksutova; Luciani Renata Silveira Carvalho; Julia Hoppmann; Julián Martínez Mayer; Frédérique Albarel; Debora Braslavsky; Ana Keselman; Ignacio Bergadá; Marcelo A Martí; Alexandru Saveanu; Anne Barlier; Rami Abou Jamra; Michael H Guo; Andrew Dauber; Marilena Nakaguma; Berenice B Mendonca; Sajini N Jayakody; A Bilge Ozel; Qing Fang; Qianyi Ma; Jun Z Li; Thierry Brue; María Ines Pérez Millán; Ivo J P Arnhold; Roland Pfaeffle; Jacob O Kitzman; Sally A Camper
Journal:  Am J Hum Genet       Date:  2021-07-15       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.